查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836821

病人参与解决方案市场（按组件、交付模式、最终用户和应用）—全球预测 2025-2032

Patient Engagement Solution Market by Component, Delivery Mode, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，病人参与解决方案市场将成长至 537.1 亿美元，复合年增长率为 14.12%。

主要市场统计数据
基准年2024年 186.6亿美元
预计2025年 213.5亿美元
预测年份：2032年 537.1亿美元
复合年增长率（%） 14.12%

权威介绍概述了病人参与平台如何改善现代医疗保健系统中的护理连续性、营运弹性和患者体验

病人参与解决方案正在重塑医疗系统与其服务对象的连结方式，加速从偶发性照护转向持续性、数据主导关係的转变。这些解决方案提供一系列功能，可增强预约安排、药物顺从性、远距医疗问诊和个人化沟通。透过实现更及时的互动和更丰富的纵向数据，这些解决方案有助于改善临床决策、营运效率和患者体验。如今，医疗保健领导者将互动平台视为关键基础设施，并将其与电子健康记录系统、收益週期工作流程和护理管理程序集成，而非可有可无的附加组件。

采用的势头源于技术的日趋成熟和相关人员不断变化的期望。行动平台的易用性、安全通讯、电话会议和智慧自动化等进步正在降低不同患者群体采用这些技术的门槛。同时，付款人和监管机构越来越重视与治疗结果、可近性和成本控制相关的指标，从而激励医疗奖励采用对利用率和依从性有显着影响的互动工具。因此，医疗保健机构正在从结合临床品质、数位包容性和长期患者关係的策略视角来评估互动解决方案，并寻求能够扩展、互通并在各个服务领域带来可衡量改进的合作伙伴和平台。

快速的技术创新、对消费者级体验的期望以及日益严格的监管如何重塑病人参与策略和供应商差异化

在技​​术创新、以结果为导向的监管以及消费者对无缝数位体验日益增长的期望的推动下，病人参与的监管格局正在经历快速的结构性变化。模组化架构和API优先平台的兴起使得电子健康记录和辅助系统的快速整合成为可能，而云端原生技术的采用则提高了可扩展性和价值实现速度。这些技术变革正在减少医疗系统在寻求跨患者群体和临床路径部署参与能力时所遇到的阻力。

同时，反映更广泛消费者技术体验的使用者期望正推动开发人员优先考虑直觉的设计、可访问性和多通路互动。远端医疗和远端监控的日益普及正在扩大参与堆迭中服务的范围，从预约安排到用药提醒和虚拟就诊。这种转变正在提升互通性、资料安全性和可衡量的成果，使其成为解决方案供应商的竞争优势。提供者和付款人现在专注于建立伙伴关係关係，以实现基于实际利用率数据的整合数位化护理历程、营运分析和持续改进週期。

评估 2025 年关税改革如何改变综合病人参与硬体和软体生态系统的采购、筹资策略和部署时间表

2025年贸易伙伴推出的关税政策变更对支持病人参与的生态系统产生了重大的下游影响，尤其是硬体组件、周边设备和进口基础设施。许多参与解决方案依赖软体和硬体的混合，包括安全自助服务终端、即时护理设备、远端监控感测器和整合远距远端保健。由于这些实体元素依赖跨境供应链，关税和海关手续的复杂性增加了采购成本并延长了前置作业时间，迫使采购团队重新评估供应商关係和库存策略。

虽然软体元素受关税影响较小，但昂贵或稀缺的硬体可能会改变整合解决方案的整体成本结构。面对设备资本支出的增加，医疗保健机构可能会推迟更广泛的合作项目的推出阶段，或优先考虑以软体为中心的模组，例如预约管理或用药提醒等对硬体依赖程度较低的模组。为此，一些供应商加快了与国内製造商的合作，扩大了采购选择，并修改了设备规格，以减少受最高关税影响的组件。在涉及资料中心硬体进口的情况下，云端和託管策略也进行了重新调整，长期采购计画现在明确地将关税风险和供应商冗余作为关键决策标准。

累积影响超越了采购经济学。计划经理和实施团队目前正在将应急计划纳入其时间表和风险暂存器，临床负责人正在评估分阶段推出的方案，以在不过度依赖硬体发货的情况下保留核心参与优势。付款人和合约团队目前正在监控成本转嫁效应，并调整合约机制以在降低短期价格波动的同时保持价值。简而言之，2025年的关税环境正在促使对整个价值链进行策略性重新评估，倾向于灵活的、软体主导的参与模式和多样化的供应策略，以保持患者服务的可及性和连续性。

关键细分洞察揭示了元件、交付模型、最终用户需求和应用管道如何整合以形成采用和价值实现

细緻的细分方法揭示了功能元件、交付模式、最终用户群和应用程式之间的不同采用模式和技术优先顺序。纵观各个组件，咨询、实施和支援等服务在确保永续部署方面发挥核心作用，而专注于预约管理、用药提醒和远端医疗的软体模组则构成了驱动日常患者互动的营运支柱。这意味着买家通常会评估专业服务和套装软体功能的组合，以适应其组织准备和临床医生的工作流程。

交付模式会显着影响配置时间表和整体拥有成本。云端服务对于注重敏捷性的组织极具吸引力，它们可以部署为私有云端公共云端以实现快速扩展和成本效益。相反，本地部署，无论是针对紧密整合的企业环境定制，还是配置为直接部署到传统基础架构中，都适合需要掌控自身环境和整合路径的机构。最终用户，无论是管理慢性病还是寻求一般护理，都需要直觉的行动和网路存取。公共和私人支付方都希望获得能够提高合规性并降低利用率的参与机制。

应用通路偏好会影响设计选择和开发优先顺序。 Android 和 iOS 平台上的行动应用程式支援即时互动和通知，从而提高依从性和参与度；而分为患者门户网站入口网站门户，则充当详细记录审查、通讯和护理协调的中心。因此，有效的策略应将每个组件的功能与交付考虑、最终用户需求和应用管道设计相结合，以创建一个可跨服务线和患者群体进行客製化的、具有凝聚力的解决方案。

监管重点、基础设施成熟度和付款人动态将如何推动美洲、欧洲、中东和非洲以及亚太地区的差异化采用路径和部署策略

区域动态正在影响策略重点、监管考虑和部署模式，从而在全球主要市场中形成不同的采用路径。在美洲，重点关注能够展现可扩展性、支付方整合和营运效率，同时满足不同州和国家隐私法规的解决方案。各组织正在优先考虑能够支持在不同临床环境中快速采用并提供可靠分析以监控参与结果的伙伴关係。

在欧洲、中东和非洲，监管协调、不断演变的报销结构以及数位健康计划正推动人们关注互通性、资料保护和包容性设计。在某些市场，政府主导的计画和国家数位健康策略正在加速远端医疗和远端患者监护的普及，而医疗服务提供者也在寻求能够帮助他们应对复杂的跨境资料流和合规制度的解决方案。

亚太地区既具有快速应用的潜力，也体现了基础设施成熟度的多样性。大型城市中心通常优先考虑行动优先的互动策略和公共云端的采用，而新兴市场则需要能够可靠运作的解决方案，即使连接性和设备性能存在差异。因此，区域策略将扩充性与在地化相结合，支援多语言介面、离线功能以及与本地系统整合商的伙伴关係，以确保永续的采用和文化相关性。

关键供应商动态显示互通性、安全性、伙伴关係和创新合约模式将如何决定竞争定位和买家偏好

领先供应商之间的竞争态势表明，他们在互通性、安全性和已证实的临床效果方面重点趋于一致。投资于开放 API 和基于标准的整合的公司将透过简化 EHR 连接并使生态系统合作伙伴能够扩展功能而获得优势。安全性和资料管治仍然是关键挑战。能够证明其具备严格的第三方审核、强大的加密实践和稳健的身份管理框架的供应商正在赢得企业买家和注重隐私的监管机构的信任。

策略伙伴关係，尤其是将临床专业知识与软体敏捷性结合的合作伙伴关係，能够加速解决方案的成熟和市场吸引力。技术供应商、设备製造商和医疗保健系统之间的协作，能够推动与临床医生工作流程和患者需求相符的产品蓝图。此外，收购和少数股权投资越来越多地旨在填补能力差距，例如整合高级分析、行为引导技术和语言在地化，使现有企业能够提供更广泛、更具凝聚力的套件。

收益和合约模式的创新也值得关注。尝试基于绩效的合约、模组化授权和託管服务选项的供应商正在减少采购摩擦，并展现出与组织风险接受度的一致性。最终，那些在产品深度、实施支援和可衡量的价值命题之间取得平衡的公司将在买家的选择过程中占据最佳位置。

为领导者提供切实可行的建议，以加速采用、降低实施风险并使病人参与策略与临床和商业优先事项保持一致

产业领导者可以透过专注于减少摩擦、改善结果并强化其商业性定位的实际措施来加速影响力。首先，优先考虑模组化、可互通的架构，以便分阶段采用并与电子健康记录和辅助系统无缝整合。其次，设计参与途径时要注重公平性和可近性，确保行动和网路体验能够适应各种设备类型、连接水平和不同的患者群体，从而避免扩大医疗保健差距。

领导者还应将可衡量的绩效指标纳入所有部署，使临床团队和相关人员能够持续追踪依从性、预约利用率和患者满意度。使用这些指标来迭代工作流程整合和传播策略。在供应方面，应实现采购多元化，并考虑采用软体优先的方法，因为硬体依赖性会带来漏洞。透过将参与计划与报销奖励和记录在案的疗效相结合，加强与付款人和基于价值的项目的伙伴关係。最后，投资变革管理和倡议赋能，以减少采用障碍。培训、简化的工作流程和行政支援对于维持利用率和展示参与投资的长期回报至关重要。

一种透明的混合调查方法，结合主要相关人员的参与、次要技术分析和检验，以确保有效性和可复製性。

这些见解背后的研究依赖于一种混合调查方法，该方法将初步定性研究与严格的次要分析和技术检验相结合。初步研究包括与医疗服务提供者係统、付款方组织、解决方案供应商和实施合作伙伴的相关人员进行结构化访谈和研讨会，以收集关于采用驱动因素、营运障碍和价值实现的第一手观点。此外，还进行了专家小组和临床医生圆桌讨论，以检验工作流程假设和临床影响路径。

我们的二次分析整合了官方监管指南、供应商产品文件、数位健康成果学术文献以及相关技术领域的趋势分析。我们的技术检验包括整合方法的情境测试、安全框架的评估以及跨云端和本地环境的部署模型评估。我们的数据整合优先考虑三角测量。当多个独立资讯来源的发现趋于一致时，这些见解就更具可信度。因此，读者应将这些发现视为策略基础，以便将其与最新的区域法规和供应商蓝图保持一致。调查方法强调透明度、可重复性和相关人员的检验，以确保与决策者的实际相关性。

简洁的结论表明，可互通、全面且指标主导的参与策略对于将技术转化为持续的临床和营运价值至关重要。

病人参与解决方案已从新颖性变为必需品，成为医疗系统基础设施中不可或缺的一部分，支援医疗服务的连续性、病患体验和营运韧性。模组化软体功能、云端交付选项和行动优先应用的整合，使组织能够实施有针对性的干预措施，解决预约存取、用药依从性和远端就诊等问题，同时又不中断核心临床工作流程。如今，策略性采用取决于选择可互通、安全的解决方案，这些解决方案能够提供可衡量的成果，并可根据当地情况和法律规范进行客製化。

供应链压力、价值驱动型法规以及不断变化的消费者期望的累积影响将继续影响采购和部署策略。采用灵活架构、实现采购多元化并设计全面使用者体验的组织将最有可能保持更高的参与度。最终，成功不仅取决于技术选择，还取决于整合临床领导力、付款人协调和营运变革管理，将平台的功能转化为健康结果和病患满意度的持续改善。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将人工智慧聊天机器人和虚拟助理整合到患者沟通工作流程中
  • 推出即时健康分析仪表板的远端患者监护平台
  • 透过预测分析和巨量资料整合实施个人化护理计划
  • 扩展远端医疗参与工具，优化慢性病管理和照护协调
  • 使用穿戴式医疗设备主动监测和介入患者行为
  • 多通路通讯平台的进步，实现了跨装置的无缝患者-提供者互动
  • 解决隐私法规问题，重点关注病患资料安全和符合 HIPAA 要求的数位参与解决方案

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章病人参与解决方案市场（按组成部分）

  • 服务
    • 咨询
    • 执行
    • 支援
  • 软体
    • 预约管理
    • 用药提醒
    • 远端医疗

第九章。病人参与解决方案市场（按交付方式）

  • 云
    • 私有云端
    • 公共云端
  • 本地部署
    • 自订部署
    • 直接部署

第 10 章。病人参与解决方案市场（按最终用户）

  • 病人
    • 慢性病人
    • 普通病人
  • 付款人
    • 政府
    • 私人的
  • 提供者
    • 诊所
    • 医院

第 11 章。病人参与解决方案市场（按应用）

  • 行动应用程式
    • 安卓
    • iOS
  • 入口网站
    • 患者门户网站
    • 提供者入口网站

第 12 章病人参与解决方案市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章病人参与解决方案市场：按组

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章病人参与解决方案市场（按国家/地区）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Epic Systems Corporation
    • Cerner Corporation
    • Allscripts Healthcare Solutions, Inc.
    • Koninklijke Philips NV
    • McKesson Corporation
    • NextGen Healthcare, Inc.
    • GetWellNetwork, Inc.
    • Welltok, Inc.
    • Medisafe, Inc.
    • Conversa Health, Inc.
Product Code: MRR-030EE485159B

The Patient Engagement Solution Market is projected to grow by USD 53.71 billion at a CAGR of 14.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 18.66 billion
Estimated Year [2025] USD 21.35 billion
Forecast Year [2032] USD 53.71 billion
CAGR (%) 14.12%

An authoritative introduction outlining how patient engagement platforms elevate care continuity, operational resilience, and patient experience in modern health systems

Patient engagement solutions are reshaping the interface between health systems and the individuals they serve, accelerating a shift from episodic care to continuous, data-driven relationships. These solutions span a range of capabilities that enhance appointment coordination, medication adherence, remote consultation, and personalized communication. By enabling more timely interactions and richer longitudinal data, they support improved clinical decision-making, operational efficiency, and patient experience. Health leaders now view engagement platforms as critical infrastructure rather than optional adjuncts, integrating them with electronic health record systems, revenue cycle workflows, and care management programs.

Adoption momentum is rooted in both technology maturation and evolving stakeholder expectations. Advances in mobile platform usability, secure messaging, teleconferencing, and intelligent automation have reduced barriers to use for diverse patient cohorts. At the same time, payers and regulators increasingly prioritize measures tied to outcomes, access, and cost containment, creating incentives for providers to adopt engagement tools that demonstrably affect utilization and adherence. Consequently, organizations are evaluating engagement solutions through strategic lenses that combine clinical quality, digital inclusion, and long-term patient relationships, seeking partners and platforms that can scale, interoperate, and deliver measurable improvements across service lines.

How rapid technological innovation, consumer-grade experience expectations, and regulatory emphasis are reshaping patient engagement strategies and vendor differentiation

The landscape for patient engagement has experienced rapid, structural shifts driven by technological innovation, regulatory emphasis on outcomes, and heightened consumer expectations for seamless digital experiences. The rise of modular architectures and API-first platforms has enabled faster integrations with electronic health records and ancillary systems, while cloud-native deployments have improved scalability and time-to-value. These technological changes have reduced the friction for health systems seeking to deploy engagement capabilities across patient populations and clinical pathways.

Concurrently, user expectations that mirror broader consumer technology experiences are pushing developers to prioritize intuitive design, accessibility, and multi-channel interaction. The increasing acceptance of telehealth and remote monitoring is expanding the range of services considered part of the engagement stack, from appointment scheduling to medication reminders and virtual consultations. These shifts elevate interoperability, data security, and measurable outcomes as competitive differentiators for solution providers. Providers and payers are now focusing on partnerships that enable cohesive digital care journeys, operational analytics, and continuous improvement cycles driven by real-world usage data.

Assessing how tariff changes in 2025 have reshaped procurement, sourcing strategies, and deployment timelines for integrated patient engagement hardware and software ecosystems

Tariff policy changes introduced by trade partners in 2025 have had material downstream effects on the ecosystem that supports patient engagement technologies, particularly where hardware components, peripheral devices, and imported infrastructure are concerned. Many engagement solutions rely on a hybrid blend of software and hardware: secure kiosks, point-of-care devices, remote monitoring sensors, and integrated telehealth carts. Where these physical elements depend on cross-border supply chains, increased duties and customs complexity have raised procurement costs, prolonged lead times, and forced procurement teams to reassess vendor relationships and inventory strategies.

Software elements are less directly affected by tariffs, yet the overall cost structure of integrated solutions can shift when hardware becomes more expensive or scarce. Providers faced with increased capital expenditure for devices may delay rollout phases of broader engagement programs, or they may prioritize software-centric modules such as appointment management and medication reminders that have lower hardware dependencies. In response, some vendors have accelerated partnerships with domestic manufacturers, expanded sourcing options, and adapted device specifications to reduce components subject to the highest duties. Cloud and hosting strategies have also been recalibrated where data center hardware imports are implicated, and long-term procurement plans now explicitly incorporate tariff risk and supplier redundancy as key decision criteria.

The cumulative impact extends beyond procurement economics. Project managers and implementation teams now build contingency allowances into timelines and risk registers, while clinical leadership evaluates phased rollouts that maintain core engagement benefits without over-reliance on hardware shipments. Payers and contracting teams monitor cost pass-through effects and adjust contracting mechanisms to preserve value while mitigating short-term price shocks. In short, the tariff environment of 2025 has prompted a strategic reassessment across the value chain, favoring flexible, software-led engagement models and diversified supply strategies that preserve accessibility and continuity of patient services.

Key segmentation insights illuminating how components, delivery models, end user needs, and application channels converge to shape adoption and value realization

A nuanced segmentation approach reveals different adoption patterns and technology priorities across functional components, delivery modes, end user groups, and applications. When looking at components, services such as consulting, implementation, and support play a central role in ensuring sustainable deployments, while software modules focused on appointment management, medication reminders, and telehealth form the operational backbone that drives daily patient interactions. This means buyers typically evaluate a combination of professional services and packaged software capability to match organizational readiness and clinician workflows.

Delivery mode significantly influences deployment cadence and total cost of ownership considerations. Cloud offerings, whether deployed as private cloud to meet stringent data residency or security requirements or public cloud for rapid scalability and cost efficiency, appeal to organizations prioritizing agility. Conversely, on premise deployments, whether customized for tightly integrated enterprise environments or configured for direct deployment in legacy infrastructures, resonate with institutions that need control over the environment and integration pathways. End users shape requirements in meaningful ways: patients, whether managing chronic conditions or seeking general care, demand intuitive mobile and web access; payers, public or private, focus on engagement mechanisms that demonstrate improved compliance and reduced utilization; providers, including clinics and hospitals, require solutions that fit within clinical workflows and do not add administrative burden.

Application channel preferences influence design choices and development priorities. Mobile apps, delivered across Android and iOS platforms, enable real-time engagement and notifications that drive adherence and participation, while web portals, differentiated into patient portals and provider portals, serve as hubs for detailed record review, messaging, and care coordination. Effective strategies therefore merge component capability with delivery considerations, end user needs, and application channel design to produce cohesive solutions that can be tailored across lines of service and patient populations.

How regional regulatory priorities, infrastructure maturity, and payer dynamics in the Americas, Europe Middle East & Africa, and Asia-Pacific drive differentiated adoption paths and deployment strategies

Regional dynamics influence strategic priorities, regulatory considerations, and deployment models, yielding different pathways to adoption across major global markets. In the Americas, emphasis centers on scalability, payer integration, and solutions that can demonstrate operational efficiency while meeting diverse state and national privacy regulations. Organizations prioritize partnerships that can support rapid implementation across disparate clinical settings and offer robust analytics to monitor engagement outcomes.

Across Europe, Middle East & Africa, regulatory harmonization efforts, evolving reimbursement structures, and digital health initiatives drive a focus on interoperability, data protection, and inclusive design. In some markets, government-led programs and national digital health strategies accelerate adoption of telehealth and remote patient monitoring components, while providers seek solutions that can navigate complex cross-border data flows and compliance regimes.

The Asia-Pacific region presents both rapid adoption potential and heterogeneity in infrastructure maturity. Large urban centers often prioritize mobile-first engagement strategies and public cloud deployments, while emerging markets require solutions that perform reliably across variable connectivity and device capabilities. Regional strategies therefore blend scalability with localization, supporting multilingual interfaces, offline functionality, and partnerships with local system integrators to ensure sustainable adoption and cultural relevance.

Key vendor dynamics showing how interoperability, security, partnerships, and innovative contracting models determine competitive position and buyer preference

Competitive dynamics among leading vendors reveal converging priorities around interoperability, security, and demonstrable clinical impact. Companies investing in open APIs and standards-based integrations gain advantage by simplifying EHR connectivity and enabling ecosystem partners to extend functionality. Security and data governance remain table stakes: vendors that can evidence rigorous third-party audits, strong encryption practices, and robust identity management frameworks earn trust from enterprise buyers and privacy-focused regulators.

Strategic partnerships, particularly those that combine clinical expertise with software agility, accelerate solution maturity and market traction. Collaboration between technology vendors, device manufacturers, and healthcare systems fosters product roadmaps that align with clinician workflows and patient needs. Additionally, a growing number of acquisitions and minority investments aim to close gaps in capability-such as embedding advanced analytics, behavioral nudging techniques, or language localization-allowing incumbents to offer broader, more cohesive suites.

Innovation in monetization and contracting models is also notable. Vendors experimenting with outcome-aligned agreements, modular licensing, and managed services options are reducing procurement friction and demonstrating alignment with organizational risk appetites. Ultimately, companies that balance product depth with implementation support and measurable value propositions position themselves most favorably in buyer selection processes.

Actionable recommendations for leaders to accelerate adoption, reduce implementation risk, and align patient engagement strategies with clinical and commercial priorities

Industry leaders can accelerate impact by focusing on practical levers that reduce friction, enhance outcomes, and strengthen commercial positioning. First, prioritize modular, interoperable architectures that enable phased adoption and seamless integration with electronic health records and ancillary systems; this reduces implementation risk and allows rapid realization of core benefits. Second, design engagement pathways that center equity and accessibility, ensuring that mobile and web experiences work across device types, connectivity levels, and diverse patient populations to avoid widening care disparities.

Leaders should also embed measurable performance indicators into every deployment, ensuring that clinical teams and commercial stakeholders can track adherence, appointment utilization, and patient satisfaction over time. Use these metrics to iterate on workflow integrations and communication strategies. From a supply perspective, diversify sourcing and consider software-first approaches where hardware dependencies create vulnerability. Strengthen partnerships with payers and value-based programs by aligning engagement initiatives with reimbursement incentives and documented outcomes. Finally, invest in change management and clinician enablement to reduce adoption barriers: training, streamlined workflows, and administrative support are critical to sustain usage and demonstrate the long-term return on engagement investments.

A transparent blended research methodology combining primary stakeholder engagements, secondary technical analysis, and validation to ensure relevance and reproducibility

The research underpinning these insights relies on a blended methodology that combines primary qualitative engagement with rigorous secondary analysis and technical validation. Primary research included structured interviews and workshops with stakeholders across provider systems, payer organizations, solution vendors, and implementation partners to capture firsthand perspectives on adoption drivers, operational barriers, and value realization. These engagements were complemented by expert panels and clinician roundtables to validate workflow assumptions and clinical impact pathways.

Secondary analysis incorporated public regulatory guidance, vendor product documentation, academic literature on digital health outcomes, and trend analysis in adjacent technology sectors. Technical validation involved scenario testing of integration approaches, evaluation of security frameworks, and assessment of deployment models across cloud and on premise environments. Data synthesis prioritized triangulation: where multiple independent sources converged on the same finding, the insight was elevated in confidence. Limitations include the rapid evolution of software releases and regional policy updates; accordingly, readers should consider these findings as a strategic foundation to be contextualized against the latest local regulations and vendor roadmaps. The methodology emphasizes transparency, reproducibility, and stakeholder validation to ensure practical relevance to decision-makers.

A concise conclusion arguing that interoperable, inclusive, and metrics-driven engagement strategies are essential to translate technology into lasting clinical and operational value

Patient engagement solutions have moved from novelty to necessity, forming an essential layer of health system infrastructure that supports continuity of care, patient experience, and operational resilience. The convergence of modular software capabilities, cloud delivery options, and mobile-first applications has enabled organizations to implement targeted interventions that address appointment access, medication adherence, and remote consultations without disrupting core clinical workflows. Strategic adoption now hinges on selecting interoperable, secure solutions that offer measurable outcomes and can be adjusted to local conditions and regulatory frameworks.

The cumulative impacts of supply chain pressures, regulatory emphasis on value, and evolving consumer expectations will continue to shape procurement and deployment strategies. Organizations that embrace flexible architectures, diversify sourcing, and design inclusive user experiences will be best positioned to sustain engagement gains. Ultimately, success depends not only on technology selection but on the integration of clinical leadership, payer alignment, and operational change management to translate platform capabilities into sustained improvements in health outcomes and patient satisfaction.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven chatbots and virtual assistants into patient communication workflows
  • 5.2. Adoption of remote patient monitoring platforms with real-time health analytics dashboards
  • 5.3. Implementation of personalized care plans through predictive analytics and big data integration
  • 5.4. Expansion of telehealth engagement tools optimized for chronic disease management and care coordination
  • 5.5. Use of wearable medical devices for proactive patient behavior monitoring and engagement interventions
  • 5.6. Advancement of multi-channel communication platforms for seamless patient-provider interactions across devices
  • 5.7. Focus on patient data security and HIPAA-compliant digital engagement solutions in response to privacy regulations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Patient Engagement Solution Market, by Component

  • 8.1. Services
    • 8.1.1. Consulting
    • 8.1.2. Implementation
    • 8.1.3. Support
  • 8.2. Software
    • 8.2.1. Appointment Management
    • 8.2.2. Medication Reminders
    • 8.2.3. Telehealth

9. Patient Engagement Solution Market, by Delivery Mode

  • 9.1. Cloud
    • 9.1.1. Private Cloud
    • 9.1.2. Public Cloud
  • 9.2. On Premise
    • 9.2.1. Customized Deployment
    • 9.2.2. Direct Deployment

10. Patient Engagement Solution Market, by End User

  • 10.1. Patients
    • 10.1.1. Chronic Patients
    • 10.1.2. General Patients
  • 10.2. Payers
    • 10.2.1. Government
    • 10.2.2. Private
  • 10.3. Providers
    • 10.3.1. Clinics
    • 10.3.2. Hospitals

11. Patient Engagement Solution Market, by Application

  • 11.1. Mobile Apps
    • 11.1.1. Android
    • 11.1.2. iOS
  • 11.2. Web Portals
    • 11.2.1. Patient Portal
    • 11.2.2. Provider Portal

12. Patient Engagement Solution Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Patient Engagement Solution Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Patient Engagement Solution Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Epic Systems Corporation
    • 15.3.2. Cerner Corporation
    • 15.3.3. Allscripts Healthcare Solutions, Inc.
    • 15.3.4. Koninklijke Philips N.V.
    • 15.3.5. McKesson Corporation
    • 15.3.6. NextGen Healthcare, Inc.
    • 15.3.7. GetWellNetwork, Inc.
    • 15.3.8. Welltok, Inc.
    • 15.3.9. Medisafe, Inc.
    • 15.3.10. Conversa Health, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. PATIENT ENGAGEMENT SOLUTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. PATIENT ENGAGEMENT SOLUTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PATIENT ENGAGEMENT SOLUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, B